Skip to main content

Advertisement

SpringerLink
Log in

The Role of PGRN in Alzheimer’s Disease

  • Published:
Molecular Neurobiology Aims and scope Submit manuscript

Abstract

Progranulin (PGRN), a multifunctional growth factor expressed in various tissues, is involved in a diversity of physiologic and pathological processes, including cell proliferation, wound healing, and modulation of inflammation. Interest in the role of progranulin in the brain has increased dramatically since mutations in GRN, which encodes for the protein PGRN, are associated with the pathogenesis of Alzheimer’s disease (AD). A great many of studies suggest that PGRN participates in AD pathogenesis through diverse pathways, including Aβ deposition and clearance, intraneuronal deposition of phosphorylated tau, neuroinflammation, and neuronal survival. Decreased GRN mRNA levels can be detected in the parietal lobe of patients clinically diagnosed with AD; more importantly, emerging data support that serum or plasma PGRN can act as a biomarker for AD. By understanding PGRN in a wider context, we may be better able to depict its role in AD and then provide a therapeutic strategy for AD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Sy M, Kitazawa M, Medeiros R, Whitman L, Cheng D, Lane TE, Laferla FM (2011) Inflammation induced by infection potentiates tau pathological features in transgenic mice. Am J Pathol 178(6):2811–2822. doi:10.1016/j.ajpath.2011.02.012

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Lauren Herl Martens JZ, Sami J. Barmada, Ping Zhou, Sherry Kamiya, Binggui Sun, Sang-Won Min, Li Gan, Steven Finkbeiner, Eric J. Huang, Robert V. Farese Jr. (2014) Progranulin deficiency promotes neuroinflammation and neuron loss following toxin-induced injury. doi:10.1172/jci63113ds1

  3. Progranulin and b-amyloid distribution: a case report of the brain from preclinical PS-1 mutation carrier (2009).

  4. Sheng J, Su L, Xu Z, Chen G (2014) Progranulin polymorphism rs5848 is associated with increased risk of Alzheimer’s disease. Gene 542(2):141–145. doi:10.1016/j.gene.2014.03.041

    Article  CAS  PubMed  Google Scholar 

  5. Bertram L, Lill CM, Tanzi RE (2010) The genetics of Alzheimer disease: back to the future. Neuron 68(2):270–281. doi:10.1016/j.neuron.2010.10.013

    Article  CAS  PubMed  Google Scholar 

  6. Holtzman DM, Morris JC, Goate AM (2011) Alzheimer’s disease: the challenge of the second century. Sci Transl Med 3(77), 77sr71. doi:10.1126/scitranslmed.3002369

    Article  Google Scholar 

  7. Paola Bossù AC, Francesca Salani, Diego Vanni, Ilaria Palladino, Carlo Caltagirone, Giuseppe Scapigliati (2010) Interleukin-18, from neuroinflammation to Alzheimers disease

  8. Lu RC, Tan MS, Wang H, Xie AM, Yu JT, Tan L (2014) Heat shock protein 70 in Alzheimer’s disease. BioMed Res Int 2014:435203. doi:10.1155/2014/435203

    PubMed  PubMed Central  Google Scholar 

  9. Li Y, Tan MS, Jiang T, Tan L (2014) Microglia in Alzheimer’s disease. BioMed Res Int 2014:437483. doi:10.1155/2014/437483

    PubMed  PubMed Central  Google Scholar 

  10. Ou JR, Tan MS, Xie AM, Yu JT, Tan L (2014) Heat shock protein 90 in Alzheimer’s disease. BioMed Res Int 2014:796869. doi:10.1155/2014/796869

    Article  PubMed  PubMed Central  Google Scholar 

  11. Toh H, Chitramuthu BP, Bennett HP, Bateman A (2011) Structure, function, and mechanism of progranulin; the brain and beyond. J Mol Neurosci: MN 45(3):538–548. doi:10.1007/s12031-011-9569-4

    Article  CAS  PubMed  Google Scholar 

  12. Wu H, Siegel RM (2011) Progranulin resolves inflammation. Science 332(6028):427–428. doi:10.1126/science.1205992

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Jian J, Konopka J, Liu C (2013) Insights into the role of progranulin in immunity, infection, and inflammation. J Leukoc Biol 93(2):199–208. doi:10.1189/jlb.0812429

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Lewis SDAJ (2014) Understanding the role of progranulin in Alzheimer’s disease. Nat Med 20. doi:10.1038/nm.371210.1016/j.biopsych.2014.05.006

  15. De Muynck L, Herdewyn S, Beel S, Scheveneels W, Van Den Bosch L, Robberecht W, Van Damme P (2013) The neurotrophic properties of progranulin depend on the granulin E domain but do not require sortilin binding. Neurobiol Aging 34(11):2541–2547. doi:10.1016/j.neurobiolaging.2013.04.022

    Article  PubMed  Google Scholar 

  16. Perry DC, Lehmann M, Yokoyama JS, Karydas A, Lee JJ, Coppola G, Grinberg LT, Geschwind D et al (2013) Progranulin mutations as a risk factor for Alzheimer’s disease. JAMA Neurol 70(6):774–778. doi:10.1001/2013.jamaneurol.393

    Article  PubMed  PubMed Central  Google Scholar 

  17. Kamalainen A, Viswanathan J, Natunen T, Helisalmi S, Kauppinen T, Pikkarainen M, Pursiheimo JP, Alafuzoff I et al (2013) GRN variant rs5848 reduces plasma and brain levels of granulin in Alzheimer’s disease patients. J Alzheimer’s Dis: JAD 33(1):23–27. doi:10.3233/JAD-2012-120946

    CAS  PubMed  Google Scholar 

  18. Lee MJ, Chen TF, Cheng TW, Chiu MJ (2011) rs5848 variant of progranulin gene is a risk of Alzheimer’s disease in the Taiwanese population. Neurodegener Dis 8(4):216–220. doi:10.1159/000322538

    Article  CAS  PubMed  Google Scholar 

  19. Filiano AJ, Martens LH, Young AH, Warmus BA, Zhou P, Diaz-Ramirez G, Jiao J, Zhang Z et al (2013) Dissociation of frontotemporal dementia-related deficits and neuroinflammation in progranulin haploinsufficient mice. J Neurosci : Off J Soc Neurosci 33(12):5352–5361. doi:10.1523/JNEUROSCI.6103-11.2013

    Article  CAS  Google Scholar 

  20. Minami SS, Min SW, Krabbe G, Wang C, Zhou Y, Asgarov R, Li Y, Martens LH et al (2014) Progranulin protects against amyloid beta deposition and toxicity in Alzheimer’s disease mouse models. Nat Med 20(10):1157–1164. doi:10.1038/nm.3672

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Masato Hosokawa P, Tetsuaki Arai, MD, PhD, Masami Masuda-Suzukake, PhD, Hiromi Kondo, Takashi Matsuwaki, DVM, PhD, Masugi Nishihara, DVM, PhD, Masato Hasegawa, PhD, and Haruhiko Akiyama, MD, PhD (2015) Progranulin reduction is associated with increased tau phosphorylation in P301L tau transgenic mice. J Neuropathol Exp Neurol

  22. Gibbons L, Rollinson S, Thompson JC, Robinson A, Davidson YS, Richardson A, Neary D, Pickering-Brown SM et al (2014) Plasma levels of progranulin and interleukin-6 in frontotemporal lobar degeneration. Neurobiol Aging. doi:10.1016/j.neurobiolaging.2014.10.023

    PubMed  Google Scholar 

  23. Cenik B, Sephton CF, Kutluk Cenik B, Herz J, Yu G (2012) Progranulin: a proteolytically processed protein at the crossroads of inflammation and neurodegeneration. J Biol Chem 287(39):32298–32306. doi:10.1074/jbc.R112.399170

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Pickford F, Marcus J, Camargo LM, Xiao Q, Graham D, Mo JR, Burkhardt M, Kulkarni V et al (2011) Progranulin is a chemoattractant for microglia and stimulates their endocytic activity. Am J Pathol 178(1):284–295. doi:10.1016/j.ajpath.2010.11.002

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Sleegers BVB (2010) Role of progranulin as a biomarker for Alzheimer’s disease. Biomarkers Med: 37-50

  26. Zhu J, Nathan C, Jin W, Sim D, Ashcroft GS, Wahl SM, Lacomis L, Erdjument-Bromage H et al (2002) Conversion of proepithelin to epithelins: roles of SLPI and elastase in host defense and wound repair. Cell 111(6):867–878

    Article  CAS  PubMed  Google Scholar 

  27. Kai Kessenbrock LF, Michael Sixt, Tim Lämmermann, Heiko Pfister AB, Azzaq Belaaouaj, Johannes Ring, Markus Ollert RF, Dieter E. Jenne (2008) Proteinase 3 and neutrophil elastase enhance inflammation in mice by inactivating antiinflammatory progranulin. doi:10.1172/jci34694ds1

  28. Tang W, Lu Y, Tian QY, Zhang Y, Guo FJ, Liu GY, Syed NM, Lai Y et al (2011) The growth factor progranulin binds to TNF receptors and is therapeutic against inflammatory arthritis in mice. Science 332(6028):478–484. doi:10.1126/science.1199214

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Van Damme P, Van Hoecke A, Lambrechts D, Vanacker P, Bogaert E, van Swieten J, Carmeliet P, Van Den Bosch L et al (2008) Progranulin functions as a neurotrophic factor to regulate neurite outgrowth and enhance neuronal survival. J Cell Biol 181(1):37–41. doi:10.1083/jcb.200712039

    Article  PubMed  PubMed Central  Google Scholar 

  30. Tapia L, Milnerwood A, Guo A, Mills F, Yoshida E, Vasuta C, Mackenzie IR, Raymond L et al (2011) Progranulin deficiency decreases gross neural connectivity but enhances transmission at individual synapses. J Neurosci : Off J Soc Neurosci 31(31):11126–11132. doi:10.1523/JNEUROSCI.6244-10.2011

    Article  CAS  Google Scholar 

  31. Gass J, Cannon A, Mackenzie IR, Boeve B, Baker M, Adamson J, Crook R, Melquist S et al (2006) Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. Hum Mol Genet 15(20):2988–3001. doi:10.1093/hmg/ddl241

    Article  CAS  PubMed  Google Scholar 

  32. Cruts M, Gijselinck I, van der Zee J, Engelborghs S, Wils H, Pirici D, Rademakers R, Vandenberghe R et al (2006) Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature 442(7105):920–924. doi:10.1038/nature05017

    Article  CAS  PubMed  Google Scholar 

  33. Fenoglio C, Galimberti D, Cortini F, Kauwe JS, Cruchaga C, Venturelli E, Villa C, Serpente M et al (2009) Rs5848 variant influences GRN mRNA levels in brain and peripheral mononuclear cells in patients with Alzheimer’s disease. J Alzheimer’s Dis: JAD 18(3):603–612. doi:10.3233/JAD-2009-1170

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Viswanathan J, Makinen P, Helisalmi S, Haapasalo A, Soininen H, Hiltunen M (2009) An association study between granulin gene polymorphisms and Alzheimer’s disease in Finnish population. Am J Med Genet B, Neuropsychiatric Genet 150B(5):747–750. doi:10.1002/ajmg.b.30889

    Article  CAS  Google Scholar 

  35. Piaceri I, Nacmias B, Sorbi S (2013) Genetics of familial and sporadic Alzheimer’s disease. Front Biosci 5:167–177

    Article  Google Scholar 

  36. Liau LM, Lallone RL, Seitz RS, Buznikov A, Gregg JP, Kornblum HI, Nelson SF, Bronstein JM (2000) Identification of a human glioma-associated growth factor gene, granulin, using differential immuno-absorption. Cancer Res 60(5):1353–1360

    CAS  PubMed  Google Scholar 

  37. Bateman A, Bennett HP (1998) Granulins: the structure and function of an emerging family of growth factors. J Endocrinol 158(2):145–151

    Article  CAS  PubMed  Google Scholar 

  38. Ghidoni R, Paterlini A, Albertini V, Binetti G, Benussi L (2012) Losing protein in the brain: the case of progranulin. Brain Res 1476:172–182. doi:10.1016/j.brainres.2012.01.075

    Article  CAS  PubMed  Google Scholar 

  39. Ryan CL, Baranowski DC, Chitramuthu BP, Malik S, Li Z, Cao M, Minotti S, Durham HD et al (2009) Progranulin is expressed within motor neurons and promotes neuronal cell survival. BMC Neurosci 10:130. doi:10.1186/1471-2202-10-130

    Article  PubMed  PubMed Central  Google Scholar 

  40. Petkau TL, Neal SJ, Orban PC, MacDonald JL, Hill AM, Lu G, Feldman HH, Mackenzie IR et al (2010) Progranulin expression in the developing and adult murine brain. J Comp Neurol 518(19):3931–3947. doi:10.1002/cne.22430

    Article  PubMed  Google Scholar 

  41. Mukherjee O, Pastor P, Cairns NJ, Chakraverty S, Kauwe JS, Shears S, Behrens MI, Budde J et al (2006) HDDD2 is a familial frontotemporal lobar degeneration with ubiquitin-positive, tau-negative inclusions caused by a missense mutation in the signal peptide of progranulin. Ann Neurol 60(3):314–322. doi:10.1002/ana.20963

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. De Muynck L, Van Damme P (2011) Cellular effects of progranulin in health and disease. J Mol Neurosci: MN 45(3):549–560. doi:10.1007/s12031-011-9553-z

    Article  PubMed  Google Scholar 

  43. Chiang HH, Forsell C, Lilius L, Oijerstedt L, Thordardottir S, Shanmugarajan K, Westerlund M, Nennesmo I et al (2013) Novel progranulin mutations with reduced serum-progranulin levels in frontotemporal lobar degeneration. Eur J Hum Genet: EJHG 21(11):1260–1265. doi:10.1038/ejhg.2013.37

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Cellular Localization of Gene Expression for Progranulin (2000).

  45. Daniel R, Daniels E, He Z, Bateman A (2003) Progranulin (acrogranin/PC cell-derived growth factor/granulin-epithelin precursor) is expressed in the placenta, epidermis, microvasculature, and brain during murine development. Dev Dyn 227(4):593–599. doi:10.1002/dvdy.10341

    Article  CAS  PubMed  Google Scholar 

  46. Suh HS, Gelman BB, Lee SC (2014) Potential roles of microglial cell progranulin in HIV-associated CNS pathologies and neurocognitive impairment. J Neuroimmune Pharmacol 9(2):117–132. doi:10.1007/s11481-013-9495-z

    Article  PubMed  PubMed Central  Google Scholar 

  47. Yin F, Banerjee R, Thomas B, Zhou P, Qian L, Jia T, Ma X, Ma Y et al (2009) Exaggerated inflammation, impaired host defense, and neuropathology in progranulin-deficient mice. J Exp Med 207(1):117–128. doi:10.1084/jem.20091568

    Article  PubMed  Google Scholar 

  48. He Z, Ong CH, Halper J, Bateman A (2003) Progranulin is a mediator of the wound response. Nat Med 9(2):225–229. doi:10.1038/nm816

    Article  CAS  PubMed  Google Scholar 

  49. Bateman A, Bennett HP (2009) The granulin gene family: from cancer to dementia. BioEssays 31(11):1245–1254. doi:10.1002/bies.200900086

    Article  CAS  PubMed  Google Scholar 

  50. He Z, Bateman A (2003) Progranulin (granulin-epithelin precursor, PC-cell-derived growth factor, acrogranin) mediates tissue repair and tumorigenesis. J Mol Med 81(10):600–612. doi:10.1007/s00109-003-0474-3

    Article  CAS  PubMed  Google Scholar 

  51. Finch N, Baker M, Crook R, Swanson K, Kuntz K, Surtees R, Bisceglio G, Rovelet-Lecrux A et al (2009) Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members. Brain 132(Pt 3):583–591. doi:10.1093/brain/awn352

    Article  PubMed  PubMed Central  Google Scholar 

  52. Sleegers K, Brouwers N, Van Damme P, Engelborghs S, Gijselinck I, van der Zee J, Peeters K, Mattheijssens M et al (2009) Serum biomarker for progranulin-associated frontotemporal lobar degeneration. Ann Neurol 65(5):603–609. doi:10.1002/ana.21621

    Article  CAS  PubMed  Google Scholar 

  53. Body fluid biomarkers in Alzheimer’s disease (2015). doi:10.3978/j.issn.2305-5839.2015.02.13

  54. Mandrekar S, Jiang Q, Lee CY, Koenigsknecht-Talboo J, Holtzman DM, Landreth GE (2009) Microglia mediate the clearance of soluble Abeta through fluid phase macropinocytosis. J Neurosci : Off J Soc Neurosci 29(13):4252–4262. doi:10.1523/JNEUROSCI.5572-08.2009

    Article  CAS  Google Scholar 

  55. Yin F, Dumont M, Banerjee R, Ma Y, Li H, Lin MT, Beal MF, Nathan C et al (2010) Behavioral deficits and progressive neuropathology in progranulin-deficient mice: a mouse model of frontotemporal dementia. FASEB J 24(12):4639–4647. doi:10.1096/fj.10-161471

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Pereson S, Wils H, Kleinberger G, McGowan E, Vandewoestyne M, Van Broeck B, Joris G, Cuijt I et al (2009) Progranulin expression correlates with dense-core amyloid plaque burden in Alzheimer disease mouse models. J Pathol 219(2):173–181. doi:10.1002/path.2580

    Article  CAS  PubMed  Google Scholar 

  57. Medina M, Avila J (2014) New perspectives on the role of tau in Alzheimer’s disease. Implications for therapy. Biochem Pharmacol 88(4):540–547. doi:10.1016/j.bcp.2014.01.013

    Article  CAS  PubMed  Google Scholar 

  58. Inflammation induced by infection potentiates tau pathological features in transgenic mice (2011). doi: 10.1016/j.ajpath.2011.02.012

  59. Wang JZ, Wang ZH, Tian Q (2014) Tau hyperphosphorylation induces apoptotic escape and triggers neurodegeneration in Alzheimer’s disease. Neurosci Bull 30(2):359–366. doi:10.1007/s12264-013-1415-y

    Article  PubMed  Google Scholar 

  60. Zhang X, Hernandez I, Rei D, Mair W, Laha JK, Cornwell ME, Cuny GD, Tsai LH et al (2013) Diaminothiazoles modify tau phosphorylation and improve the tauopathy in mouse models. J Biol Chem 288(30):22042–22056. doi:10.1074/jbc.M112.436402

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. Lee DC, Rizer J, Selenica ML, Reid P, Kraft C, Johnson A, Blair L, Gordon MN et al (2010) LPS-induced inflammation exacerbates phospho-tau pathology in rTg4510 mice. J Neuroinflammation 7:56. doi:10.1186/1742-2094-7-56

    Article  PubMed  PubMed Central  Google Scholar 

  62. Tanaka Y, Matsuwaki T, Yamanouchi K, Nishihara M (2013) Exacerbated inflammatory responses related to activated microglia after traumatic brain injury in progranulin-deficient mice. Neuroscience 231:49–60. doi:10.1016/j.neuroscience.2012.11.032

    Article  CAS  PubMed  Google Scholar 

  63. Baker M, Mackenzie IR, Pickering-Brown SM, Gass J, Rademakers R, Lindholm C, Snowden J, Adamson J et al (2006) Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 442(7105):916–919. doi:10.1038/nature05016

    Article  CAS  PubMed  Google Scholar 

  64. Eimer WA, Vassar R (2013) Neuron loss in the 5XFAD mouse model of Alzheimer’s disease correlates with intraneuronal Aβ42 accumulation and caspase-3 activation. Molecular Neurodegeneration 8:2. doi:10.1186/1750-1326-8-2

  65. Uberti D, Cantarella G, Facchetti F, Cafici A, Grasso G, Bernardini R, Memo M (2004) TRAIL is expressed in the brain cells of Alzheimer’s disease patients. Neuroreport 15(4):579–581

    Article  CAS  PubMed  Google Scholar 

  66. Neutralization of TRAIL death pathway protects human neuronal cell line from b-amyloid toxicity (2003). doi:10.1038/

  67. Salminen A, Ojala J, Kauppinen A, Kaarniranta K, Suuronen T (2009) Inflammation in Alzheimer’s disease: amyloid-β oligomers trigger innate immunity defence via pattern recognition receptors. Prog Neurobiol 87(3):181–194. doi:10.1016/j.pneurobio.2009.01.001

    Article  CAS  PubMed  Google Scholar 

  68. Neuroinflammation in Alzheimer’s disease; a source of heterogeneity and target for personalized therapy (2014). doi:10.1016/j.neuroscience.2014.09.061

  69. Varvel NH, Bhaskar K, Kounnas MZ, Wagner SL, Yang Y, Lamb BT, Herrup K (2009) NSAIDs prevent, but do not reverse, neuronal cell cycle reentry in a mouse model of Alzheimer disease. J Clin Invest 119(12):3692–3702. doi:10.1172/JCI39716

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  70. Neuroinflammation in the pathogenesis of Alzheimer’s disease. A rational framework for the search of novel therapeutic approaches (2014). doi:10.3389/fncel.2014.00112

  71. Jian J, Zhao S, Tian Q, Gonzalez-Gugel E, Mundra JJ, Uddin SM, Liu B, Richbourgh B et al (2013) Progranulin directly binds to the CRD2 and CRD3 of TNFR extracellular domains. FEBS Lett 587(21):3428–3436. doi:10.1016/j.febslet.2013.09.024

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by grants from the National Natural Science Foundation of China (81471309, 81371406, 81171209), Qingdao Key Health Discipline Development Fund, Qingdao Outstanding Health Professional Development Fund, and Shandong Provincial Collaborative Innovation Center for Neurodegenerative Disorders.

Conflict of Interest

The authors declare no conflicts of interest.

Author information

Authors and Affiliations

  1. Department of Neurology, Qingdao Municipal Hospital, School of Medicine, Qingdao University, Qingdao, China

    Hua Jing, Meng-Shan Tan, Jin-Tai Yu & Lan Tan

  2. Memory and Aging Center, Department of Neurology, University of California, San Francisco, CA, USA

    Jin-Tai Yu

Authors
  1. Hua Jing
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Meng-Shan Tan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jin-Tai Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lan Tan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Jin-Tai Yu or Lan Tan.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jing, H., Tan, MS., Yu, JT. et al. The Role of PGRN in Alzheimer’s Disease. Mol Neurobiol 53, 4189–4196 (2016). https://doi.org/10.1007/s12035-015-9358-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12035-015-9358-0

Keywords

Search

Navigation